InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: jessellivermore post# 19220

Saturday, 10/26/2013 12:06:54 AM

Saturday, October 26, 2013 12:06:54 AM

Post# of 426504
May I suggest slightly different wording for the following passage in your letter to Dr. Hamburg at the FDA....

"This is troubling, because Vascepa because of its proven anti chronic inflammatory properties has the potential for prevention in many chronic diseases which chronic inflammation is the underlying process and diet seems to be the driver.."

might be altered to.....

"This is troubling, because Vascepa with its proven anti-inflammatory properties has the potential for prevention of many persistent diseases in which chronic inflammation is a causal factor and improper dietary intake appears to be the primary driver..."

This letter is a very well constructed and informative position statement being made to Dr. Hamburg. Hope you don't object if I plagiarize and paraphrase?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News